erlotinib tablets i.p.150mg
Erlib 150mg Tablet is a targeted anti-cancer medication used primarily for treating non-small cell lung cancer (NSCLC) that is locally advanced or has spread. It is also used in combination with gemcitabine to treat pancreatic cancer. It works as a tyrosine kinase inhibitor by blocking the epidermal growth factor receptor (EGFR), a protein that signals cancer cells to grow and divide.
Click to expand
Anti Cancer Tablets
erlotinib tablets i.p.150mg
By Neon Laboratories Ltd
₹4,215.9
WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
150 MG
Packaging
30 TABS BOTTLE
Type
Bottle of 30 tablets
Shelf Life
24 months (2 years)
Erlib 150mg Tablet is a targeted anti-cancer medication used primarily for treating non-small cell lung cancer (NSCLC) that is locally advanced or has spread. It is also used in combination with gemcitabine to treat pancreatic cancer. It works as a tyrosine kinase inhibitor by blocking the epidermal growth factor receptor (EGFR), a protein that signals cancer cells to grow and divide.
Manufacturer Info
NameNeon Laboratories Ltd
PrescriptionPrescription-only (Rx)
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.